Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
Aaron Paul Kithcart, Senior Medical Director in Translational and Clinical Sciences of Hematology at Regeneron, shared a post on LinkedIn:
“This weekend, I was in Nagasaki for the Japan College of Cardiology meeting.
It was a productive trip and a great opportunity to connect in person with investigators and colleagues participating in our FXI studies in atrial fibrillation and peripheral artery disease.
Beyond the scientific discussions, I really enjoyed learning more about Nagasaki and its unique place in Japanese history.
For centuries, Nagasaki served as Japan’s sole trading port open to foreign countries, making it an important gateway for international exchange and the exchange of ideas.
It was a great visit all around, and I’m grateful to all of the investigators and colleagues who took the time to meet, share their insights, and advance our work together.
Looking forward to many more years of collaboration and continuing the important work we are doing together in thrombosis.”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 12:04Ifeanyichukwu Ifechidere: When Coagulation Becomes Critical in Obstetrics
-
Sep 15, 2026, 11:55Yadira Torres MAS: Predicting Chronic Immune Thrombocytopenia in Children
-
Sep 15, 2026, 11:44Chokri Ben Lamine: Matching Anemia Treatment to the Myelofibrosis Patient
-
Sep 15, 2026, 11:17Adam Urato: How SSRIs May Affect Maternal and Fetal Serotonin
-
Sep 15, 2026, 11:05Sudhir Kumar: Maternal Anemia May Shape a Child’s Brain Development
-
Sep 15, 2026, 10:48Ashok Singhal: A Life-Changing Transplant Brings New Hope for Beta Thalassemia
-
Sep 15, 2026, 10:33Vera Ghali: Mitapivat Opens a New Chapter in Thalassemia Treatment
-
Sep 15, 2026, 10:13Behnood Bikdeli: Exploring the Role of Antiphospholipid Antibodies in Ischemic Stroke
-
Sep 15, 2026, 09:55Mark Mamlouk: When Postpartum Headache Signals More Than a CSF Leak